Core Viewpoint - The company, I-Wu Biotech, has received approval for a clinical trial supplement application for its drug "Dog Hair Dander Prick Liquid" from the National Medical Products Administration [2] Group 1 - The approval was obtained from the National Medical Products Administration's government service portal [2] - The clinical trial supplement application was submitted by the company [2]

Core Viewpoint - The company Iwubio (300357.SZ) has received approval for a supplementary application for clinical trials of its drug "Dog Dander Skin Prick Solution" from the National Medical Products Administration, indicating progress in its product development for diagnosing type I hypersensitivity diseases related to dog dander [1] Group 1 - The clinical trial supplementary application for the drug has been approved [1] - The drug is intended for use in skin prick tests to assist in diagnosing type I hypersensitivity diseases associated with dog dander [1]